HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins.

Abstract
Botulinum neurotoxins are bacterial proteins that cause botulism, a life-threatening disease. Therapy relies mostly on post-intoxication antibody treatment. The only accepted method to measure the potency of, and to approve, antitoxin preparations is the mouse lethality neutralization bioassay. However, this assay is time-consuming, labor-intensive, costly, and raises ethical issues related to the large numbers of laboratory animals needed. Until now, all efforts to develop an alternative in vitro assay have not provided a valid replacement to the mouse potency assay. In the present study, we report the development of an innovative in vitro assay for determining botulinum antitoxin potency, using botulinum type B as a model. The concept of the assay is to mimic two fundamental steps in botulinum intoxication: receptor binding and catalytic activity. By simulating these steps in vitro we were able to accurately determine the potency of antitoxin preparations. The reproducibility of the assay was high with a CV < 13%. Most importantly, the antitoxin potency measured by the in vitro assay highly correlated with that measured by the standard in vivo mouse assay (r = 0.9842, p < 0.0001). Thus, this new in vitro assay has the potential to be considered, after validation, as a replacement to the mouse assay for quantitating neutralizing antibody concentrations in pharmaceutical botulinum antitoxin preparations. Future adoption of this in vitro assay would minimize the use of laboratory animals, speed up the time, and reduce the cost of botulinum antitoxin approval.
AuthorsOsnat Rosen, Eyal Ozeri, Ada Barnea, Alon Ben David, Ran Zichel
JournalToxins (Toxins (Basel)) Vol. 8 Issue 10 (09 24 2016) ISSN: 2072-6651 [Electronic] Switzerland
PMID27669303 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neutralizing
  • Botulinum Antitoxin
  • Peptides
  • rimabotulinumtoxinB
  • Endopeptidases
  • Botulinum Toxins, Type A
Topics
  • Animals
  • Antibodies, Neutralizing (immunology, metabolism)
  • Biological Assay
  • Botulinum Antitoxin (immunology, metabolism)
  • Botulinum Toxins, Type A (immunology, metabolism)
  • Catalysis
  • Endopeptidases (metabolism)
  • In Vitro Techniques
  • Mice
  • Peptides (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: